Long-term management of anemia in chronic inflammatory bowel disease

被引:0
|
作者
Mickisch, O
Baniewicz, W
Lutz-Vorderbrügge, A
Schreiber, S
Küppers, B
机构
[1] Gastroenterol Schwerpunktpraxis, D-68161 Mannheim, Germany
[2] Univ Kiel, Med Klin 1, D-2300 Kiel, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2002年 / 40卷 / 04期
关键词
inflammatory bowel disease; anaemia; intravenous iron therapy; erythropoietin; immunosuppressive drugs;
D O I
10.1055/s-2002-25154
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The development of a stepwise therapy, as detailed below, can be administered to the mostly young patients with Crohn's disease and ulcerative colitis on an out-patient basis and appropriate to their needs. This is true not only for the activity of the disease, but also for extraintestinal manifestations. The numerous variations in the stepwise anti-inflammatory therapy of chronic inflammatory bowel disease, but also in the substitution therapy of deficiency states and the therapy of accompanying extraintestinal diseases provide the gastroenterologist with the possibility of a long-term treatment tailored to the needs of the individual patient.
引用
收藏
页码:241 / 248
页数:8
相关论文
共 50 条
  • [1] Management and long-term outcome of severe acute inflammatory bowel disease
    Lehur, PA
    GuiberteauCanfrere, V
    LeBorgne, J
    SEMAINE DES HOPITAUX, 1997, 73 (13-14): : 409 - 416
  • [2] Inflammatory bowel disease: long-term therapeutic challenges
    Ashton, James J.
    Green, Zachary
    Kolimarala, Vinod
    Beattie, R. Mark
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1049 - 1063
  • [3] Long-term safety of vedolizumab for inflammatory bowel disease
    Loftus, Edward V., Jr.
    Feagan, Brian G.
    Panaccione, Remo
    Colombel, Jean-Frederic
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert
    Rubin, David T.
    Shafran, Ira
    Parfionovas, Andrejus
    Rogers, Raquel
    Lirio, Richard A.
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1353 - 1365
  • [4] Long-term outcomes of pediatric inflammatory bowel disease
    Nasiri, Soheila
    Kuenzig, Mary Ellen
    Benchimol, Eric I.
    SEMINARS IN PEDIATRIC SURGERY, 2017, 26 (06) : 398 - 404
  • [5] LONG-TERM PROGNOSIS OF INFLAMMATORY BOWEL-DISEASE
    FARMER, RG
    POSTGRADUATE MEDICINE, 1981, 70 (04) : 124 - &
  • [6] Anemia in patients with chronic inflammatory bowel disease
    Cronin, CC
    Shanahan, F
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (08): : 2296 - 2298
  • [7] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    Marzo, M.
    Felice, C.
    Mocci, G.
    De Vincentis, F.
    Andrisani, G.
    Pugliese, D.
    Fedeli, P.
    De Vitis, I.
    Papa, A.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S88 - S88
  • [8] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, Alessandro
    De pascalis, Barbara
    Roberto, Italia
    Ennas, Sara
    De vincentis, Fabio
    Guglielmo, Simona
    Fedeli, Paolo
    Papa, Alfredo
    De vitis, Italo
    Gasbarrini, Giovanni
    Melina, Domenico
    Fedeli, Giuseppe
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2007, 132 (04) : A183 - A183
  • [9] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S12 - S12
  • [10] ANTIMETABOLITES IN INFLAMMATORY BOWEL-DISEASE - LONG-TERM EXPERIENCE
    KORELITZ, BI
    MOUNT SINAI JOURNAL OF MEDICINE, 1990, 57 (05): : 297 - 304